Paul Mueller Company Announces Its Second Quarter Earnings of 2024

Rhea-AI Summary

Paul Mueller Company (OTC Pink: MUEL) announced its Q2 2024 earnings. Key highlights include:

- Net sales increased 9.6% to $65.67 million for Q2 2024 compared to $59.93 million in Q2 2023.

- Net income rose to $6.8 million ($7.26 per share) in Q2 2024, up from $4.81 million ($4.43 per share) in Q2 2023.

- Backlog grew significantly to $187.3 million as of June 30, 2024, compared to $106.0 million a year ago, primarily driven by the pharmaceutical divisions.

- The company announced plans to construct a new $20 million facility, adding 100,000 square feet for expanded production and R&D.

- A tender offer resulted in the repurchase of 148,874 shares for $11.9 million at $80 per share.

Positive

• Net sales increased 9.6% year-over-year in Q2 2024
• Net income grew by 41.4% to $6.8 million in Q2 2024
• Earnings per share increased to $7.26 in Q2 2024 from $4.43 in Q2 2023
• Backlog surged to $187.3 million, up 76.7% from the previous year
• Announced plans for a new $20 million facility to expand production and R&D

Negative

• Cash and marketable securities decreased to $21.6 million after the tender offer
• Six-month net sales remained flat year-over-year at $116 million

SPRINGFIELD, Mo., July 26, 2024 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC Pink: MUEL) (the “Company”) announces its second-quarter earnings of 2024. 

PAUL MUELLER COMPANY
SIX-MONTH REPORT
Unaudited
(In thousands)
CONSOLIDATED STATEMENTS OF INCOME
			Three Months Ended								Six Months Ended								Twelve Months Ended
			June 30								June 30								June 30
			2024				2023				2024				2023				2024				2023
Net Sales			$	65,670			$	59,931			$	116,026			$	116,282			$	228,900			$	221,050
Cost of Sales				45,871				41,379				80,431				80,933				158,123				165,816
Gross Profit			$	19,799			$	18,552			$	35,595			$	35,349			$	70,777			$	55,234
Selling, General and Administrative Expense				11,417				12,714				21,775				25,301				84,743				39,675
Operating Income (Loss)			$	8,382			$	5,838			$	13,820			$	10,048			$	(13,966	)		$	15,559
Interest Income (Expense)				70				(80	)			(1,178	)			(177	)			(1,351	)			(369	)
Other Income				506				613				2,050				1,333				3,383				2,310
Income (Loss) before Provision (Benefit) for Income Taxes			$	8,958			$	6,371			$	14,692			$	11,204			$	(11,934	)		$	17,500
Provision (Benefit) for Income Taxes				2,154				1,558				3,439				2,724				(4,817	)			4,140
Net Income (Loss)			$	6,804			$	4,813			$	11,253			$	8,480			$	(7,117	)		$	13,360
Earnings (Loss) per Common Share ––	Basic and Diluted		$7.26				$4.43				$11.13				$7.81				($6.79		)		$12.31

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
	Six Months Ended
	June 30
	2024				2023
Net Income	$	11,253			$	8,480
Other Comprehensive Income (Loss), Net of Tax:
Foreign Currency Translation Adjustment		(780	)			441
Comprehensive Income	$	10,473			$	8,921

CONSOLIDATED BALANCE SHEETS
	June 30				December 31
	2024				2023
Cash and Short-Term Investments	$	3,409			$	1,883
Marketable Securities		18,169				32,042
Accounts Receivable		35,662				25,166
Reserve for Doubtful Accounts		(1,141	)
Inventories (FIFO)		44,379				45,910
LIFO Reserve		(21,310	)			(21,774	)
Inventories (LIFO)		23,069				24,136
Current Net Investments in Sales-Type Leases		29				27
Other Current Assets		5,920				3,537
Current Assets	$	85,117			$	86,791
Net Property, Plant, and Equipment		44,253				42,011
Right of Use Assets		2,280				2,421
Other Assets		2,823				2,590
Long-Term Net Investments in Sales-Type Leases		-				456
Total Assets	$	134,473			$	134,269
Accounts Payable	$	15,284			$	11,041
Current Maturities and Short-Term Debt		631				640
Current Lease Liabilities		350				402
Advance Billings		18,865				27,383
Pension Liabilities		32				32
Other Current Liabilities		26,520				19,599
Current Liabilities	$	61,682			$	59,097
Long-Term Debt		8,407				8,880
Long-Term Pension Liabilities		217				233
Other Long-Term Liabilities		1,696				1,768
Lease Liabilities		777				775
Total Liabilities	$	72,779			$	70,753
Shareholders' Investment		61,694				63,516
Total Liabilities and Shareholders' Investment	$	134,473			$	134,269

SELECTED FINANCIAL DATA
	June 30				December 31
	2024				2023
Book Value per Common Share	$	65.85			$	58.50
Total Shares Outstanding		936,837				1,085,711
Backlog	$	187,336			$	97,350

CONSOLIDATED STATEMENT OF SHAREHOLDERS' INVESTMENT
		Common Stock				Paid-in Surplus				Retained Earnings				Treasury Stock				Accumulated Other Comprehensive Income (Loss)				Total
Balance, December 31, 2023		$	1,508			$	9,708			$	67,181			$	(10,787	)		$	(4,094	)		$	63,516
Add (Deduct):
Net Income											11,253												11,253
Other Comprehensive Income, Net of Tax																			(780	)			(780	)
Dividends, $.30 per Common Share											(378	)											(378	)
Treasury Stock Acquisition															(11,910	)							(11,910	)
Other											(7	)											(7	)
Balance, June 30, 2024		$	1,508			$	9,708			$	78,049			$	(22,697	)		$	(4,874	)		$	61,694

CONSOLIDATED STATEMENT OF CASH FLOWS
	Six Months Ended June 30, 2024				Six Months Ended June 30, 2023
Operating Activities:
Net Income	$	11,253			$	8,480
Adjustment to Reconcile Net Income to Net Cash Provided by Operating Activities:
Pension Contributions (Greater) Less than Expense		(16	)			(818	)
Bad Debt (Recovery) Expense		-				(19	)
Depreciation & Amortization		3,427				3,027
Loss (Gain) on Disposal of Equipment		175				-
(Gain) on Sales of Equipment		(106	)			(33	)
Change in Assets and Liabilities
(Inc) in Accts and Notes Receivable		(9,354	)			(3,854	)
Dec (Inc) in Inventories		1,290				(3,444	)
(Inc) in Prepayments		(2,389	)			(643	)
(Inc) in Net Investment in Sales-type leases		(80	)			(69	)
Dec in Other Assets		738				307
Inc in Accounts Payable		4,242				1,330
(Dec) Inc in Accrued Income Tax		(1,165	)			1,911
(Dec) Inc in Other Accrued Expenses		(227	)			4,919
(Dec) in Advanced Billings		(8,519	)			(4,647	)
Inc (Dec) in Billings in Excess of Costs and Estimated Earnings		8,306				(2,927	)
Inc in Lease Liability for Operating		57				-
Inc in Lease Liability for Financing		-				133
Principal payments of Lease Liability for Operating		(53	)			(137	)
(Dec) Inc in Long Term Deferred Tax Liabilities		(78	)			8
(Dec) Inc in Other Long-Term Liabilities		(93	)			599
Net Cash Provided by Operating Activities	$	7,408			$	4,123
Investing Activities
Intangibles		-				(62	)
Purchases of Marketable Securities		(24,649	)			-
Proceeds from Sales of Marketable Securities		38,522				-
Proceeds from Sales of Equipment		131				67
Additions to Property, Plant, and Equipment		(6,612	)			(3,190	)
Net Cash (Required) for Investing Activities	$	7,392			$	(3,185	)
Financing Activities
Principal payments of Lease Liability for Financing		(22	)			(98	)
(Repayment) of Short-Term Borrowings, Net		(751	)			(1,673	)
Proceeds of Short-Term Borrowings, Net		754				1,673
(Repayment) of Long-Term Debt		(422	)			(318	)
Dividends Paid		(378	)			(326	)
Treasury Stock Acquisitions		(11,910	)			-
Net Cash (Required) for Financing Activities	$	(12,729	)		$	(742	)
Effect of Exchange Rate Changes		(545	)			535
Net Increase in Cash and Cash Equivalents	$	1,526			$	731
Cash and Cash Equivalents at Beginning of Year		1,883				38,176
Cash and Cash Equivalents at End of Quarter	$	3,409			$	38,907

PAUL MUELLER COMPANY
SUMMARIZED NOTES TO THE FINANCIAL STATEMENTS
(In thousands)

A.  The chart below depicts the net revenue on a consolidating basis for the three months ended June 30.

Three Months Ended June 30
Revenue	2024				2023
Domestic	$	52,830			$	48,295
Mueller BV	$	13,164			$	12,073
Eliminations	$	(324	)		$	(437	)
Net Revenue	$	65,670			$	59,931

The chart below depicts the net revenue on a consolidating basis for the six months ended June 30.

Six Months Ended June 30
Revenue	2024				2023
Domestic	$	91,707			$	93,880
Mueller BV	$	24,989			$	23,377
Eliminations	$	(670	)		$	(975	)
Net Revenue	$	116,026			$	116,282

The chart below depicts the net revenue on a consolidating basis for the twelve months ended June 30.

Twelve Months Ended June 30
Revenue	2024				2023
Domestic	$	180,833			$	176,642
Mueller BV	$	49,322			$	45,695
Eliminations	$	(1,255	)		$	(1,287	)
Net Revenue	$	228,900			$	221,050

The chart below depicts the net income (loss) on a consolidating basis for the three months ended June 30.

Three Months Ended June 30
Net Income	2024				2023
Domestic	$	6,027			$	4,705
Mueller BV	$	774			$	110
Eliminations	$	3			$	(2	)
Net Income (Loss)	$	6,804			$	4,813

The chart below depicts the net income on a consolidating basis for the six months ended June 30.

Six Months Ended June 30
Net Income	2024				2023
Domestic	$	10,075			$	9,155
Mueller BV	$	1,148			$	(660	)
Eliminations	$	30			$	(15	)
Net Income (Loss)	$	11,253			$	8,480

The chart below depicts the net income on a consolidating basis for the twelve months ended June 30.

Twelve Months Ended June 30
Net Income	2024				2023
Domestic	$	(10,408	)		$	14,322
Mueller BV	$	3,285			$	(941	)
Eliminations	$	6			$	(21	)
Net Income Loss	$	(7,117	)		$	13,360

B.  June 30, 2024 backlog is $187.3 million compared to $106.0 million at June 30, 2023. The majority of this backlog is in the U.S. where backlog is $181.2 million at June 30, 2024 compared to $98.7 million at June 30, 2023. The $82.5 million increase in U.S. backlog is from the pharmaceutical divisions. In the Netherlands, backlog is down slightly with $6.5 million on June 30, 2024 versus $7.7 million on June 30, 2023.

C.  Compared to last year, revenue is up $5.7 million (9.6%) on a three-month basis; flat on a six-month basis and up $7.9 million (3.6%) for the trailing twelve months. In the U.S., revenues show a similar pattern. Increased revenue from the pharmaceutical and food and beverage divisions are partially offset by the lower revenue from the components division coming off record revenue in late 2022 and early 2023. In the Netherlands business continues to improve with revenue above last year for all three timeframes.

Net Income is up $2.0 million for three-months; $2.8 million for six months but down $20.4 million before removing the pension settlement charges incurred in December 2023. In the Netherlands, earnings continue to improve following the business restructuring in the Spring of 2023. Efficiencies achieved from the restructuring along with strategic price increases have led to the improved earnings.

We manage our business in the U.S. looking at earnings before tax (EBT) and excluding the effects of LIFO and non-reoccurring events such as the pension settlement. This non-GAAP adjusted EBT (as shown in the table below) show improved results from the strong 2023 for all three timeframes primarily from the pharmaceutical and food and beverage divisions.

Results Ending June 30th
	Three Months Ended June 30								Six Months Ended June 30								Twelve Months Ended June 30
(In Thousands)	2024				2023				2024				2023				2024				2023
Domestic Net Income	$	6,027			$	4,705			$	10,075			$	9,155			$	(10,408	)		$	14,322
Income Tax Expense	$	1,899			$	1,468			$	3,070			$	2,873			$	(4,560	)		$	4,430
Domestic EBT - GAAP	$	7,926			$	6,173			$	13,145			$	12,028			$	(14,968	)		$	18,752
LIFO Adjustment	$	(246	)		$	424			$	(463	)		$	239			$	(619	)		$	1,528
Pension Adjustment	$	-			$	-			$	-			$	-			$	41,774			$	-
Domestic EBT - Non-GAAP	$	7,680			$	6,597			$	12,682			$	12,267			$	26,187			$	20,280

D.  On July 26, 2024, the Company announced construction of a new $20 million facility adding 100,000 square feet of additional space to expand production and research and development. The new facility will be funded through cash and potential new debt. Construction is expected to begin in the fall of 2024 and complete in the fall of 2025.

E.  On March 12, 2024, the Board of Directors authorized a tender offer effective from March 15, 2024 through May 7, 2024 for up to $10 million with the option to go to $15 million of the Company’s common stock at a price of $80 per share. On April 26, 2024, the Company announced that it would purchase shares up to $15 million. On May 7, 2024, the Company announced that the tender offer had expired with 148,874 shares tendered for $11.9 million. After the completion of the tender offer, cash and marketable securities are $21.6 million as of June 30, 2024.

F.  The consolidated financials are affected by the euro to dollar exchange rate when consolidating Mueller B.V., the Dutch subsidiary. The month-end euro to dollar exchange rate was 1.09 for June, 2023; 1.10 for December, 2023 and 1.07 for June, 2024, respectively.

This press release contains forward-looking statements that provide current expectations of future events based on certain assumptions. All statements regarding future performance growth, conditions, or developments are forward-looking statements. Actual future results may differ materially from those described in the forward-looking statements due to a variety of factors, including, but not limited to, the factors described in the Company’s Annual Report under “Safe Harbor for Forward-Looking Statements”, which is available at paulmueller.com. The Company expressly disclaims any obligation or undertaking to update these forward-looking statements to reflect any future events or circumstances.

The accounting policies related to this report and additional management discussion and analysis are provided in the 2023 annual report, available at
www.paulmueller.com.

Contact Info:  
Ken Jeffries (417) 575-9000
kjeffries@paulmueller.com
https://paulmueller.com

FAQ

What was Paul Mueller Company's (MUEL) net income for Q2 2024?

Paul Mueller Company (MUEL) reported a net income of $6.8 million for Q2 2024, up from $4.81 million in Q2 2023.

How much did Paul Mueller Company's (MUEL) backlog increase as of June 30, 2024?

Paul Mueller Company's (MUEL) backlog increased to $187.3 million as of June 30, 2024, compared to $106.0 million on June 30, 2023, representing a 76.7% increase.

What new facility did Paul Mueller Company (MUEL) announce in their Q2 2024 earnings report?

Paul Mueller Company (MUEL) announced plans to construct a new $20 million facility, adding 100,000 square feet for expanded production and research and development.

How many shares did Paul Mueller Company (MUEL) repurchase in their recent tender offer?

Paul Mueller Company (MUEL) repurchased 148,874 shares for $11.9 million at $80 per share through their recent tender offer.